Senior insider sale
SVP, Chief Medical Officer at AURINIA PHARMACEUTICALS INC. — senior position signals high conviction
$54.10M
25K shares
What this filing means
KEENAN GREG plans to sell 25K shares of AURINIA PHARMACEUTICALS INC. valued at approximately $54.10M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/2/2026ACC: 0001950047-26-005481
Officer· SVP, Chief Medical Officer
Since Feb 2026
25K
Shares to sell
$54.10M
Approx. market value
25K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of options under a registered plan
Cash
6/2/2026
25KTotal acquired25K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/2/2026 | Exercise of options under a registered plan Cash | 25K | — |
| Total | 25K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
25K
Market value
$54.10M
6/2/2026
Total
Units
25K
Value
$54.10M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/2/2026 | 25K | $54.10M | NASDAQ | Planned |
| Total | 25K | $54.10M | ||